Li Liang PhD

Assoc/Prof Li Liang’s research focuses on respiratory infection and host responses using primary cell culture, airway epithelial organoids reconstructed from clinical samples, animal models, and multi-center clinical sample analysis. His team develops innovative diagnostic and therapeutic strategies by combining basic and clinical research. He published papers in journals such as mBio, Cell Reports, Antiviral Research, ACS Applied Materials & Interfaces, BMC Genomics, Oncogene, and Cell Death and Disease. His research outcomes got a global interest in news reports for various countries, patented in US and EU, and received collaborations from pharmaceutical companies and investors. He collaborates with hospitals in China and overseas, including Nagasaki University Hospital (Japan), Centre Hospitalier Universitaire de Dijon (France), and National University Hospital (Singapore), for research that further promotes the potential clinical application of the findings in disease pathogenesis. The combination of basic and clinical research enables the bench-to-bed translation of the research findings of his team.